RCEL Quote, Financials, Valuation and Earnings

Sensus Healthcare, Inc. has a net margin of -77.29% compared to AVITA Medical, Inc.'s net margin of -13.7%. AVITA Medical, Inc.'s return on equity of -1112.54% beat Sensus Healthcare, Inc.'s return on equity of -5.65%.

AVITA Medical, Inc. has a consensus price target of $7.92, signalling upside risk potential of 124.65%. On the other hand Sensus Healthcare, Inc. has an analysts' consensus of $7.33 which suggests that it could grow by 82.88%. Given that AVITA Medical, Inc. has higher upside potential than Sensus Healthcare, Inc., analysts believe AVITA Medical, Inc. is more attractive than Sensus Healthcare, Inc..

AVITA Medical, Inc. has a beta of 1.658, which suggesting that the stock is 65.807% more volatile than S&P 500. In comparison Sensus Healthcare, Inc. has a beta of 1.236, suggesting its more volatile than the S&P 500 by 23.559%.

AVITA Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sensus Healthcare, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVITA Medical, Inc. pays -- of its earnings as a dividend. Sensus Healthcare, Inc. pays out -- of its earnings as a dividend.

AVITA Medical, Inc. quarterly revenues are $17.1M, which are larger than Sensus Healthcare, Inc. quarterly revenues of $6.9M. AVITA Medical, Inc.'s net income of -$13.2M is lower than Sensus Healthcare, Inc.'s net income of -$943K. Notably, AVITA Medical, Inc.'s price-to-earnings ratio is -- while Sensus Healthcare, Inc.'s PE ratio is 34.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVITA Medical, Inc. is 1.30x versus 1.84x for Sensus Healthcare, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of -77.29% compared to AVITA Medical, Inc.'s net margin of -862.39%. AVITA Medical, Inc.'s return on equity of -1112.54% beat VolitionRX Ltd.'s return on equity of --.

AVITA Medical, Inc. has a consensus price target of $7.92, signalling upside risk potential of 124.65%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.50 which suggests that it could grow by 779.04%. Given that VolitionRX Ltd. has higher upside potential than AVITA Medical, Inc., analysts believe VolitionRX Ltd. is more attractive than AVITA Medical, Inc..

AVITA Medical, Inc. has a beta of 1.658, which suggesting that the stock is 65.807% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

AVITA Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVITA Medical, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

AVITA Medical, Inc. quarterly revenues are $17.1M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. AVITA Medical, Inc.'s net income of -$13.2M is lower than VolitionRX Ltd.'s net income of -$5.4M. Notably, AVITA Medical, Inc.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVITA Medical, Inc. is 1.30x versus 19.49x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision, Inc. has a net margin of -77.29% compared to AVITA Medical, Inc.'s net margin of -1037.17%. AVITA Medical, Inc.'s return on equity of -1112.54% beat Catheter Precision, Inc.'s return on equity of -192.05%.

AVITA Medical, Inc. has a consensus price target of $7.92, signalling upside risk potential of 124.65%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1496.69%. Given that Catheter Precision, Inc. has higher upside potential than AVITA Medical, Inc., analysts believe Catheter Precision, Inc. is more attractive than AVITA Medical, Inc..

AVITA Medical, Inc. has a beta of 1.658, which suggesting that the stock is 65.807% more volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.

AVITA Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVITA Medical, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.

AVITA Medical, Inc. quarterly revenues are $17.1M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. AVITA Medical, Inc.'s net income of -$13.2M is lower than Catheter Precision, Inc.'s net income of -$2.3M. Notably, AVITA Medical, Inc.'s price-to-earnings ratio is -- while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVITA Medical, Inc. is 1.30x versus 11.19x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -77.29% compared to AVITA Medical, Inc.'s net margin of 3.93%. AVITA Medical, Inc.'s return on equity of -1112.54% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

AVITA Medical, Inc. has a consensus price target of $7.92, signalling upside risk potential of 124.65%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 150.92%. Given that Xtant Medical Holdings, Inc. has higher upside potential than AVITA Medical, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than AVITA Medical, Inc..

AVITA Medical, Inc. has a beta of 1.658, which suggesting that the stock is 65.807% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

AVITA Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVITA Medical, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

AVITA Medical, Inc. quarterly revenues are $17.1M, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. AVITA Medical, Inc.'s net income of -$13.2M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, AVITA Medical, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 58.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVITA Medical, Inc. is 1.30x versus 0.65x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.